Global Opioids Drug Market – Industry Trends and Forecast to 2028

Market Analysis and Insights : Global Opioids Drug Market

The opioids drug market is expected to gain growth at a potential rate of 2.52% in the forecast period of 2021 to 2028. The rise in pain management awareness programs offered by regulatory bodies, local governments, NGOs, and healthcare systems in developed and developing regions is the factor responsible for the market growth.

Opioids are one of the classes of drugs which act on opioid receptors. Clinically they are generally used for pain management including acute pulmonary edema, anesthesia, diarrhea and many more. They are also used by patients recovering from surgery or experiencing rigorous pain associated with cancer. The side effect of opioids includes nausea, sleepiness and constipation among others.

The rapid increase in awareness and concerns regarding the health of patients is expected to accelerate the market growth in the forecast period of 2021 to 2028. Likewise, the rise in prevalence of disease conditions with chronic pain such as lower back pain, cancer, arthritis and fibromyalgia and increase in road accidents and trauma, associated with constantly increasing cases of surgical procedures are also predictable to enhance the opioids drug market growth. Furthermore, the rise in usage of abuse-deterrent formulations to restrict the opioid abuse is also projected to drive the market growth rate. Also, the high consumption of opioids as a pain reliever as well as for abusive use are also expected to influence the opioids drug market growth globally.

In addition, the rapid technological advancement and the increase in the palliative care for intensely suffering patients are likely to create various new opportunities that will impact this opioids drug market growth in the forecast period of 2021 to 2028.

However, the unregulated government policies regarding the use and misuse of the opioids and rise in incidence of opioids abuse and addiction are expected to act as major restraints towards the growth of the opioids drug market, whereas the strict regulatory scenarios for opioid drugs sale can challenge the growth of the target market in the above mentioned forecast period.

This opioids drug market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis on the opioids drug market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Opioids Drug Market Scope and Market Size

The opioids drug market is segmented on the basis of product type, application and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• Based on product type, the opioids drug market is segmented into buprenorphine, fentanyl, hydrocodone, morphine, oxycodone, tramadol and others.
• The opioids drug market is also segmented on the basis of application into pain relief, anesthesia, cough suppression, diarrhea suppression and deaddiction. Pain relief has further been segmented into cancer pain, postoperative pain management, low back pain, orthopedic, fibromyalgia and neuropathic.
• On the basis of distribution channel, the opioids drug market is segmented into hospital pharmacies, retail pharmacies drug stores, clinics and others.

Opioids Drug Market Country Level Analysis

The opioids drug market is analyzed and market size information is provided by country by product type, application and distribution channel as referenced above.

The countries covered in the opioids drug market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the opioids drug market due to rise in government initiatives to combat the crisis in the U.S. Asia-Pacific region is expected to expand at a significant growth rate in the forecast period of 2021 to 2028 because of the rapid shift in the focus of the major companies towards this region with an aim to strengthen their position.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The opioids drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Opioids Drug Market Share Analysis

The opioids drug market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to opioids drug market.

The major players covered in the opioids drug market report are Allergan, Purdue Pharma L.P, Johnson & Johnson Services, Inc., Boehringer Ingelheim International GmbH, Titan Pharmaceuticals, Inc, Endo International plc, Mallinckrodt Company, Sun Pharmaceutical Industries Ltd, Sanofi, AstraZeneca, GlaxoSmithKline plc, Novartis AG, Pfizer Inc, Kamada Pharmaceuticals, Teva Pharmaceutical Industries Ltd., LUPIN, Cipher Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, Mylan N.V., and Lannett among other domestic and global players. Opioids drug market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-42470